Laura Sepp-lorenzino - Net Worth and Insider Trading
Laura Sepp-lorenzino Net Worth
The estimated net worth of Laura Sepp-lorenzino is at least $1 Million dollars as of 2024-05-02. Laura Sepp-lorenzino is the EVP, Chief Scientific Officer of Intellia Therapeutics Inc and owns about 43,927 shares of Intellia Therapeutics Inc (NTLA) stock worth over $1 Million. Details can be seen in Laura Sepp-lorenzino's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Laura Sepp-lorenzino has not made any transactions after 2024-01-08 and currently still holds the listed stock(s).
Transaction Summary of Laura Sepp-lorenzino
Laura Sepp-lorenzino Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Laura Sepp-lorenzino owns 2 companies in total, including Intellia Therapeutics Inc (NTLA) , and Taysha Gene Therapies Inc (TSHA) .
Click here to see the complete history of Laura Sepp-lorenzino’s form 4 insider trades.
Insider Ownership Summary of Laura Sepp-lorenzino
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-08 | EVP & Chief Scientific Officer |
| TSHA | Taysha Gene Therapies Inc | 2020-11-23 | director |
Laura Sepp-lorenzino Latest Holdings Summary
Laura Sepp-lorenzino currently owns a total of 1 stock. Laura Sepp-lorenzino owns 43,927 shares of Intellia Therapeutics Inc (NTLA) as of January 8, 2024, with a value of $1 Million.
Latest Holdings of Laura Sepp-lorenzino
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics Inc | 2024-01-08 | 43,927 | 23.27 | 1,022,181 |
Holding Weightings of Laura Sepp-lorenzino
Laura Sepp-lorenzino Form 4 Trading Tracker
According to the SEC Form 4 filings, Laura Sepp-lorenzino has made a total of 6 transactions in Intellia Therapeutics Inc (NTLA) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Intellia Therapeutics Inc is the sale of 2,275 shares on January 8, 2024, which brought Laura Sepp-lorenzino around $65,679.
Insider Trading History of Laura Sepp-lorenzino
- 1
Laura Sepp-lorenzino Trading Performance
Laura Sepp-lorenzino Ownership Network
Laura Sepp-lorenzino Owned Company Details
What does Intellia Therapeutics Inc do?
Who are the key executives at Intellia Therapeutics Inc?
Laura Sepp-lorenzino is the EVP & Chief Scientific Officer of Intellia Therapeutics Inc. Other key executives at Intellia Therapeutics Inc include EVP & Chief Business Officer Derek Hicks , EVP & Chief Technical Officer Eliana Clark , and director & President and CEO John M. Leonard .
Intellia Therapeutics Inc (NTLA) Insider Trades Summary
Over the past 18 months, Laura Sepp-lorenzino made 3 insider transaction in Intellia Therapeutics Inc (NTLA) with a net sale of 12,645. Other recent insider transactions involving Intellia Therapeutics Inc (NTLA) include a net sale of 11,996 shares made by Eliana Clark , a net sale of 2,397 shares made by Muna Bhanji , and a net sale of 25,896 shares made by John M. Leonard .
In summary, during the past 3 months, insiders sold 0 shares of Intellia Therapeutics Inc (NTLA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 79,775 shares of Intellia Therapeutics Inc (NTLA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 79,775 shares.
Intellia Therapeutics Inc (NTLA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Intellia Therapeutics Inc Insider Transactions
Laura Sepp-lorenzino Mailing Address
Above is the net worth, insider trading, and ownership report for Laura Sepp-lorenzino. You might contact Laura Sepp-lorenzino via mailing address: C/o Intellia Therapeutics, Inc., 40 Erie Street, Suite 130, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
